Zomagen Biosciences Belgium SRL

6.2 FTE

Zomagen Biosciences Belgium reported total assets of €1.83m at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026), with 6.2 full-time equivalents.

By total assets for 2025, Zomagen Biosciences Belgium ranks in the top half of the 994 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0744.519.837 · VAT BE0744519837
9052 Ghent
active in Research and experimental development on biotechnology (NACE 72101)
operating since 27 Feb 2020 (≈ 6 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Zomagen Biosciences Belgium shows with a free account.

See the score
Profile
SRL Micro · 6.2 FTE since 2020
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result87,406 €
Equity467,552 €
Cash157,782 €
EBITDA174,391 €
Total assets€1.83m
Headcount (avg FTE)6.2
The line marks its sector median: 60.4% (425 companies).

Change 2022 → 2025: Equity +121 % Total assets -22 % Headcount (avg FTE) +59 %

Accounts of the company itself (not consolidated).

The full file covers 5 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Zomagen Biosciences Belgium's annual accounts

20252024202320222021
Net result87,406 €
Equity467,552 €
Cash157,782 €
EBITDA174,391 €
Total assets€1.83m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 06 Jul 2026
  • Year ended 31 Dec 2024filed on 27 Jun 2025
  • Year ended 31 Dec 2023filed on 02 Jul 2024
  • Year ended 31 Dec 2022filed on 30 Jun 2023
  • Year ended 31 Dec 2021filed on 05 Jul 2022

Zomagen Biosciences Belgium's financial analysis

Management and control of Zomagen Biosciences Belgium

2 active director(s) in the register.

Zomagen Biosciences Belgium's shareholders and holdings →

Zomagen Biosciences Belgium's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0744.519.837
VAT number
BE0744519837
Peppol
Registered · 0208:0744519837 · as of 10 Nov 2026
Legal form
SRL
Incorporated
27 Feb 2020
Registered office
9052 Ghent
Size
Micro · 6.2 FTE
Latest accounts
2025 · filed on 06 Jul 2026
Activity
Research and experimental development on biotechnology (NACE 72101)

Zomagen Biosciences Belgium (SRL) has been based in Ghent since 2020, active in: research and experimental development on biotechnology. For 2025, it reports a net profit of 87,406 € and equity of 467,552 €; its revenue is not published. With 6.2 full-time equivalents, it is a micro-enterprise by headcount.

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Zomagen Biosciences Belgium

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Zomagen Biosciences Belgium

What is the revenue of Zomagen Biosciences Belgium?

Zomagen Biosciences Belgium files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Zomagen Biosciences Belgium?

In Belgium, the VAT number is the company number prefixed with BE: BE0744519837 for Zomagen Biosciences Belgium, if the company is VAT-registered. Its company number (CBE) is 0744.519.837.

Where is the registered office of Zomagen Biosciences Belgium?

According to the CBE register, the registered office of Zomagen Biosciences Belgium is in 9052 Ghent.

What is the equity of Zomagen Biosciences Belgium?

At the close of the 2025 financial year, the equity of Zomagen Biosciences Belgium amounts to 467,552 €, a solvency of 25.5% of total assets.

How many people work at Zomagen Biosciences Belgium?

6.2 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Zomagen Biosciences Belgium?

The register lists 2 active mandates at Zomagen Biosciences Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Zomagen Biosciences Belgium within its sector?

By total assets for 2025, Zomagen Biosciences Belgium ranks in the top half of the 994 companies in its sector (NACE 7210) in Belgium that filed accounts for that financial year.

Idonis

The full file of Zomagen Biosciences Belgium

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 12 Aug 2026

No credit card, no commitment.

What each plan unlocks →